Miscarriage
Conditions
Keywords
miscarriage, sublingual, vaginal, misoprostol
Brief summary
The aim of this work is to compare the effectiveness of vaginal versus sub-lingual misoprostol for medical treatment of the second trimester missed miscarriage
Detailed description
In women with second trimester-missed miscarriage, sublingual misoprostol may be as vaginal misoprostol in the achievement of successful miscarriage so our aim was to compare the effectiveness of vaginal versus sub-lingual misoprostol for medical treatment of the second trimester missed miscarriage.
Interventions
All patients will receive three doses of sublingual misoprostol every four hours The first dose of misoprostol 800 mcg will be administrated at the hospital. Then the patient will be observed for 1 hour for any immediate adverse reaction Clear instructions about the method and timing of second dose will be given upon sending home. Two doses of misoprostol 800 mcg each (four tablets of 200 mcg per dose). Paracetamol, eight hourly, will be provided as analgesic or antipyretic. A specimen bottle to collect the POC if passed out. Two pairs of disposable gloves. Pre-filled histopathological examination form to be sent to the laboratory together with the products of conception
DRUGvaginal misoprostol
All patients will receive three doses of vaginal misoprostol every four hours The first dose of misoprostol 800 mcg will be administrated at the hospital. Then the patient will be observed for 1 hour for any immediate adverse reaction Clear instructions about the method and timing of the second dose will be given upon sending home. Paracetamol, eight hourly, will be provided as analgesic or antipyretic
Sponsors
Aswan University Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Masking description
an open-label randomized controlled study
Intervention model description
an open-label randomized controlled study
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
No
Inclusion criteria
* All women above 18 years of age * between 13-26 weeks of gestation. * Pregnancy is confirmed by a pregnancy test or ultrasound scan. * missed abortion * Normal general and gynecological examination.
Exclusion criteria
* Hemodynamically unstable. * Suspected sepsis with temperature 38 °C. * Concurrent medical illness e.g. hematological, cardiovascular, thromboembolism, * respiratory illnesses, recent liver disease, or pruritus of pregnancy. * Presence of intrauterine contraceptive device (IUCD). * Suspect or proven ectopic pregnancy. * -Failed medical or surgical evacuation before the presentation. * Known allergy to misoprostol.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Completeness of abortion | 7 days | expulsion of Products of conception by visual inspection |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Successful medical abortion | 7 days | cervical os is closed with endometrial thickness of less than 15 mm |
| Bleeding pattern following treatment | 7 days | This will be assessed by hemoglobin(g/dl) and haematocrit level after the treatment , if the patients required blood transfusion and number of units transfused and number of days of bleeding |
Countries
Egypt
Contacts
Primary ContactHany F Sallam, md
Backup Contactnahla w Shady, md
Outcome results
None listed